{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:28:30Z","timestamp":1692642510361},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.clinthera.2010.10.001","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T09:11:28Z","timestamp":1290417088000},"page":"1968-1976","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: An open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers"],"prefix":"10.1016","volume":"32","author":[{"given":"Tae-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Goo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.10.001_bib1","series-title":"Williams Hematology","article-title":"Anemia of chronic renal failure","author":"Caro","year":"2006"},{"key":"10.1016\/j.clinthera.2010.10.001_bib2","series-title":"Goodman & Oilman's Manual of Pharmacology and Therapeutics","article-title":"Hematopoietic agents: Growth factors, minerals, and vitamins","author":"Kaushansky","year":"2008"},{"key":"10.1016\/j.clinthera.2010.10.001_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.10.001_bib4","series-title":"Procrit (epoetin alfa) [package insert]","year":"2008"},{"key":"10.1016\/j.clinthera.2010.10.001_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/clpt.1991.210","article-title":"Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta","volume":"50","author":"Halstenson","year":"1991","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.10.001_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0091270004268411","article-title":"Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers","volume":"44","author":"Ramakrishnan","year":"2004","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.10.001_bib7","series-title":"Quantikine IVD Human EPO EIA kit [package insert]","year":"2009"},{"key":"10.1016\/j.clinthera.2010.10.001_bib8","series-title":"Bioequivalence and Statistics in Clinical Pharmacology","author":"Patterson","year":"2006"},{"key":"10.1016\/j.clinthera.2010.10.001_bib9","series-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland","year":"1995"},{"key":"10.1016\/j.clinthera.2010.10.001_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.2004.02151.x","article-title":"A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection","volume":"58","author":"Togawa","year":"2004","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.10.001_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bdd.231","article-title":"Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers","volume":"21","author":"Cheung","year":"2000","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.clinthera.2010.10.001_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00241652","article-title":"Diurnal variations of serum erythropoietin in trained and untrained subjects","volume":"67","author":"Klausen","year":"1993","journal-title":"Eur J Appl Physiol Occup Physiol."},{"key":"10.1016\/j.clinthera.2010.10.001_bib14","series-title":"Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development","article-title":"Bioequivalence of biologics","author":"Barrett","year":"2006"},{"key":"10.1016\/j.clinthera.2010.10.001_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2369-6-5","article-title":"Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on he- modialysis: A parallel, randomized, double blind study","volume":"6","author":"P\u00e9rez-Oliva","year":"2005","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinthera.2010.10.001_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1124\/dmd.107.015248","article-title":"Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin","volume":"35","author":"Woo","year":"2007","journal-title":"Drug Metab Dispos."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:51:20Z","timestamp":1544118680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0149291810003401"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.10.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}